Scientific American Series: Emerging Trends in Immuno-Oncology

Bristol-Myers Squibb is underwriting a series in partnership with Scientific American to highlight emerging trends in Immuno-Oncology (I-O) and their impact on the future of cancer care.

November 26, 2018

A

s part of our focus to better understand cancer biology and the intersection with the immune system, we’ve partnered with Scientific American to underwrite an editorial series highlighting emerging trends in I-O, with a particular focus on biomarkers. The series, which kicked off during the Society for Immunotherapy of Cancer 32nd Annual Meeting, will feature perspectives from Bristol-Myers Squibb researchers on the latest challenges and discoveries in I-O.

The #1 Challenge in Cancer Research

Using the immune system to fight cancer has been a groundbreaking scientific advancement, but researchers are still working to bring this science to more patients.